| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/23/2006 | US20060063268 Method and article for analyte concentration free of intermediate transfer |
| 03/23/2006 | US20060063267 Non-precipitating bodily fluid analysis system |
| 03/23/2006 | US20060063262 Wafer characteristics via reflectometry |
| 03/23/2006 | US20060063260 Method for producing a support carrying immobilized viruses, and the use of such a support |
| 03/23/2006 | US20060063258 Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders |
| 03/23/2006 | US20060063256 Human regulatory T cells and uses thereof |
| 03/23/2006 | US20060063247 Increased thermostability, photostability, and water solubility |
| 03/23/2006 | US20060063235 DNA encoding the human serine protease C-E |
| 03/23/2006 | US20060063230 Sulfatases and methods of use thereof |
| 03/23/2006 | US20060063220 Charcoal stabilization of phenyl phosphates |
| 03/23/2006 | US20060063218 Micropressors, devices and methods for use in analyte monitoring systems |
| 03/23/2006 | US20060063216 Method for diagnosing a predisposition of psychosis in a progeny |
| 03/23/2006 | US20060063215 Human GAK-related gene variants associated with lung cancer |
| 03/23/2006 | US20060063214 Methods and compositions for diagnosing neoplastic disease |
| 03/23/2006 | US20060063213 Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
| 03/23/2006 | US20060063212 Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
| 03/23/2006 | US20060063211 Method of cancer screening and method of cancer treatment |
| 03/23/2006 | US20060063210 Histone deacetylase whole cell enzyme assay |
| 03/23/2006 | US20060063209 Engineered antibody fragment that irreversibly binds an antigen |
| 03/23/2006 | US20060063208 DRG11-responsive (DRAGON) gene and uses thereof |
| 03/23/2006 | US20060063207 Protein patterning can be achieved by providing surface which is substantially non-adherent to proteins, but which is capable of acquiring an electrical charge; upon charging surface, protein molecules become reversibly bound, binding of which can be changed by lowering, removing, or reversing charge |
| 03/23/2006 | US20060063204 such as annexins, natrietic precursor protein, and enolase; high speed immunoassay; for early detection and differentiation of stable/unstable angina and myocardial infarction |
| 03/23/2006 | US20060063203 Vascular endothelial cell growth factor variants and uses thereof |
| 03/23/2006 | US20060063202 High throughput method and system for screening candidate compounds for activity against epilepsy and other neurological diseases |
| 03/23/2006 | US20060063201 Crystals of the Fc region of immunoglobulin epsilon heavy chain protein |
| 03/23/2006 | US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/23/2006 | US20060063199 Using Nourin-1 (an inflammatory peptide) as a marker for cardiac ischemia; can be detected within minutes in blood samples obtained from patients experiencing acute coronary syndromes because it is released within 5 minutes |
| 03/23/2006 | US20060063198 Using Nourin-1 (an inflammatory peptide) as a marker for cardiac ischemia; can be detected within minutes in blood samples obtained from patients experiencing acute coronary syndromes because it is released within 5 minutes |
| 03/23/2006 | US20060063197 Quality control and normalization methods for protein microarrays |
| 03/23/2006 | US20060063196 the specific binding pair member is generally bonded to the bar code through a linking group; bar code may be read during translocation through a single nano-meter scale pore; screening and diagnostic applications. |
| 03/23/2006 | US20060063195 Binding surface |
| 03/23/2006 | US20060063194 Methods and probes for the detection of cancer |
| 03/23/2006 | US20060063192 Nucleic acid sequencing by Raman monitoring of molecular deconstruction |
| 03/23/2006 | US20060063190 Methods and compositions for evaluating breast cancer prognosis |
| 03/23/2006 | US20060063185 Methods for detection of pathogens in red blood cells |
| 03/23/2006 | US20060063178 Optical sensor and methods for measuring molecular binding interactions |
| 03/23/2006 | US20060063173 Charge switch nucleotides |
| 03/23/2006 | US20060063172 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample |
| 03/23/2006 | US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 03/23/2006 | US20060063162 Biological marker for inflammation |
| 03/23/2006 | US20060063158 Analyzing preferential nucleotide sequence; obtain nucleotide sequences, fragment, incubate with adaptor sequences, ligate, denature sequences, incubate with primer and amplify sequences, evaluate hybridizaton pattern; detecting a single nucleotide polymorphism (SNP) allele in in a genomic DNA |
| 03/23/2006 | US20060063155 Synthesizing the nanoparticles in a synthesis mixture and growing the nanoparticles during a synthesis period; adding a modifying reagent to the synthesis mixture; for coupling to biologically relevant molecules |
| 03/23/2006 | US20060063153 Interaction detecting method and bioassay device, and bioassay-use substrate |
| 03/23/2006 | US20060063149 Compositions and methods for detecting pathogen infection |
| 03/23/2006 | US20060063146 Method for assessment of particles |
| 03/23/2006 | US20060063145 Mass spectrometric differentiation of tissue states |
| 03/23/2006 | US20060063144 Methods for identifying stem cells based on nuclear morphotypes |
| 03/23/2006 | US20060062999 Particle size of 1-10 mu m, coercive force of 2.39-11.94 kA/m (30-150 oersted), saturation magnetization of 0.5-40 A.m2/kg (0.5-40 emu/g; peak value of wavelength of fluorescence is 350-750 nm when the particle is excited by light with a wavelength of 250-600 nm; diagnoses and environmental assessment |
| 03/23/2006 | US20060062852 Medical device for analyte monitoring and drug delivery |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062794 Composition containing particle surface charge control agent, particle separating method using same, particle separator |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062779 Methods and compositions relating to mannuronic acid specific binding peptides |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | US20060062759 Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
| 03/23/2006 | US20060062755 medical diagnosis using tumor markers; concurrent transdermal administration of imiquimod and injection of vaccines containing tumor necrosis factors; anticarcinogenic agents |
| 03/23/2006 | US20060062730 Increasing transdermal absorption by mixing isostearyl alcohol with a substance such as hair growing agent, a gray-hair prevention agent, a hair-removing agent, a hair-dyeing agent, or a hair-bleaching agent; pantothenyl ethyl ether, minoxidil, or beta-glycyrrhetinic acid |
| 03/23/2006 | US20060062727 Compositions and methods for the diagnosis and treatment of tumor |
| 03/23/2006 | US20060062694 liquid electrode mixture comprising: platinum black catalyst; water; 1-propanol; and a polymer mixture of PTFE and water; may further contain surfactants, emollients, or flocculants; may be used to detect gases such as ethanol |
| 03/23/2006 | US20060062509 Self-referencing waveguide grating sensors |
| 03/23/2006 | US20060061371 Probe for physical properties measurement |
| 03/23/2006 | US20060060316 Biopulp for non-woody fiber plants and biopulping method thereof |
| 03/23/2006 | US20060060003 Cantilever sensor using both the longitudinal and the transversal piezoresistive coefficients |
| 03/23/2006 | DE4437758B4 Bildanalyseverfahren und -vorrichtung für Strömungspartikel Image analysis method and apparatus for particle flow |
| 03/23/2006 | DE20221515U1 Apparatus for carrying out agglutination tests comprises two plates which are sealed together, inlets in upper plate connecting with channels of same length and volume on either side which lead to reaction chambers |
| 03/23/2006 | DE19851876B4 Verfahren zum Kontrollieren von Einschlüssen von hochreinem Stahl A method of controlling inclusions of high purity steel |
| 03/23/2006 | DE102005034454A1 Combustion engine lubricant or coolant consumption measurement procedure uses isotope spectrometry of non-radioactive tracer isotopes |
| 03/23/2006 | DE102005027214A1 Innenluft/Aussenluft-Wechselsteuereinheit zum Fahrzeuggebrauch Inside / outside air switching control unit for vehicle use |
| 03/23/2006 | DE102004042729A1 Bio-Chip mit einem Elektrodenarray auf einem Substrat Bio-chip with an electrode array on a substrate |
| 03/23/2006 | DE102004042530A1 Polypeptidmarker zur Diagnose von Arteriosklerose Polypeptide markers for diagnosing arteriosclerosis |
| 03/23/2006 | DE102004038607A1 Verfahren zur Bestimmung des organisch gebundenen Kohlenstoffs (TOC) Method for the determination of total organic carbon (TOC) |
| 03/23/2006 | DE102004037081A1 Hybridization assay of nucleic acid, useful particularly for identifying nitrogen-fixing microorganisms, where the complex formed includes a lable in, or close to, the hybrid region |
| 03/23/2006 | DE102004025224B4 Quantitative dermination of hydrogen sulfide in gases, e.g. for monitoring waste gases, using flow system with biosensor comprising sulfur-oxidizing bacteria immobilized on oxygen sensor and/or pH sensor |
| 03/23/2006 | CA2587813A1 Smart tray for dispensing medicaments |
| 03/23/2006 | CA2587033A1 Food quality indicator |
| 03/23/2006 | CA2583199A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections |
| 03/23/2006 | CA2581045A1 Breast cancer proteins |
| 03/23/2006 | CA2580669A1 Pathologic model animal for nonalcoholic steatohepatitis |
| 03/23/2006 | CA2580662A1 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 03/23/2006 | CA2580107A1 Growth factor treatment for asthma |
| 03/23/2006 | CA2580011A1 Method of accelerating somatic mutations and use thereof in proteomics |
| 03/23/2006 | CA2579848A1 Immobilized probes and methods of detecting conformationally altered prion proteins |
| 03/23/2006 | CA2579809A1 Metabolite markers for weight management |
| 03/23/2006 | CA2579500A1 Sampling method and sampling device, and logd measuring method and logd measuring system |
| 03/23/2006 | CA2579370A1 Methods and compositions for measuring canine bnp and uses thereof |
| 03/23/2006 | CA2579141A1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/23/2006 | CA2579105A1 Process for evaluating a refinery feedstock |
| 03/23/2006 | CA2579003A1 Process for evaluating a refinery feedstock |
| 03/23/2006 | CA2577989A1 Cytokine-expressing cellular vaccines for treatment of prostate cancer |
| 03/23/2006 | CA2577133A1 Polypeptide variants with altered effector function |
| 03/23/2006 | CA2576940A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2006 | CA2576768A1 Method of reducing the effects of a.beta. and compositions therefore |
| 03/23/2006 | CA2576435A1 Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
| 03/23/2006 | CA2576354A1 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 03/23/2006 | CA2575803A1 Progesterone receptor structure |
| 03/23/2006 | CA2572632A1 Busulfan immunoassay |
| 03/23/2006 | CA2571625A1 Free chlorine sensor |
| 03/23/2006 | CA2520670A1 Nanocrystal coated surfaces |